CAN HYPERBARIC ATMOSPHERES BE USED TO TREAT POISONING BY DEPRESSANT DRUGS

被引:0
作者
KING, LA
机构
来源
HUMAN TOXICOLOGY | 1986年 / 5卷 / 03期
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
引用
收藏
页码:215 / 215
页数:1
相关论文
共 50 条
  • [41] Can probiotics be used to treat allergic diseases?
    Tang, Ren-Bin
    Chang, Jia-Kan
    Chen, Hui-Lan
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2015, 78 (03) : 154 - 157
  • [42] JAKi: Can it be used to treat SAPHO syndrome?
    Yue, Qingyun
    Ma, Mingwei
    Liu, Shengyan
    Wu, Yuanhao
    Li, Chen
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [43] Robust neuroprotective effects of the mood stabilizers lithium and valproate: Can these drugs be used to treat neurodegenerative diseases?
    Chuang, DM
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 14S - 14S
  • [44] Drug treatment for oral submucous fibrosisQuestion: What drugs can be used to treat oral submucous fibrosis?
    Punnya V Angadi
    Evidence-Based Dentistry, 2010, 11 (2) : 56 - 56
  • [45] CHANGING PATTERN OF DRUGS USED FOR SELF-POISONING
    PROUDFOOT, AT
    PARK, J
    BRITISH MEDICAL JOURNAL, 1978, 1 (6105) : 90 - 93
  • [46] Hyperbaric oxygen therapy used to treat radiation injury: Two case reports
    Yildiz, S
    Cimsit, M
    Ilgezdi, S
    Uzun, G
    Gumus, T
    Qyrdedi, T
    Dalci, D
    OSTOMY WOUND MANAGEMENT, 2006, 52 (05) : 14 - +
  • [47] The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis
    Heath, Gregory
    Airody, Archana
    Gale, Richard Peter
    DRUGS, 2017, 77 (03) : 303 - 311
  • [48] Design and optimization of drugs used to treat copper deficiency
    Cakic, Milorad
    Mitic, Zarko
    Nikolic, Goran
    Savic, Ivan
    Savic, Ivana M.
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (10) : 1253 - 1263
  • [49] SHOULD NONSTEROIDAL ANTIINFLAMMATORY DRUGS BE USED TO TREAT OSTEOARTHRITIS
    BRANDT, KD
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1993, 19 (01) : 29 - 44
  • [50] Pharmacology of drugs used to treat osteoarthritis in veterinary practice
    Peter Lees
    InflammoPharmacology, 2003, 11 (4-6) : 385 - 399